Found: 9
Select item for more details and to access through your institution.
Fully Automated Production of [ 68 Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15101, doi. 10.3390/ijms242015101
- By:
- Publication type:
- Article
Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10745, doi. 10.3390/ijms221910745
- By:
- Publication type:
- Article
Correction to: Advances in the automated synthesis of 6-[18F]Fluoro-L-DOPA.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Advances in the automated synthesis of 6-[18F]Fluoro-L-DOPA.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00126-z
- By:
- Publication type:
- Article
Advances in the automated synthesis of 6-[18F]Fluoro-L-DOPA.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00126-z
- By:
- Publication type:
- Article
Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets.
- Published in:
- Molecules, 2024, v. 29, n. 6, p. 1390, doi. 10.3390/molecules29061390
- By:
- Publication type:
- Article
Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach.
- Published in:
- Molecules, 2023, v. 28, n. 12, p. 4670, doi. 10.3390/molecules28124670
- By:
- Publication type:
- Article
Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 939, doi. 10.3390/pharmaceutics14050939
- By:
- Publication type:
- Article
Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 6, p. 723, doi. 10.3390/ph15060723
- By:
- Publication type:
- Article